Effects of Ba Duan Jin Training for Older People

Effects of Ba Duan Jin on Muscle Strength, Balance, Cardiorespiratory Endurance, Body Composition and Quality of Life of Older People

Baduanjin is one of the widely circulated fitness methods. The Ministry of Health, the Ministry of Education and the General Administration of Sports of China have vigorously promoted it as one of the contents of health and physical education classes, and promoted it as a health Qigong method throughout mainland China. It can be seen that Baduanjin's gentle and non-aggressive movements are suitable for physical training for people of all ages.

Study Overview

• Status: Completed
• Conditions: Exercise; Old Age
• Intervention / Treatment: Behavioral: Ba duan jin

• Study Type: Interventional
• Enrollment (Actual): 78
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Taiwan
  • Taichung, Taiwan
    • Show Chwan Memorial Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• (1) old person able to communicate and follow instructions, (2) stable and with sufficient physical strength: able to maintain at least one sitting position in a wheelchair or on the edge of a bed.

Exclusion Criteria:

• (1) Difficulty standing or walking and obvious musculoskeletal disease, (2) Diagnosed and recommended by a physician Those who are not suitable for sports activities, (3) serious diseases/unstable conditions, such as severe cardiopulmonary, liver and kidney diseases, severe malignant tumors, severe malnutrition, severe dementia, (4) more than 180 minutes of exercise per week in the past month time, (5) severe arrhythmia, (6) no intention to participate.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Ba duan jin training; twice a week	Behavioral: Ba duan jin; a kind of exercise
No Intervention: usual care; once a week with video

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Chang in muscle strength from baseline to 12 weeks	pinch, grip and quadriceps strength. A Higher score means a better outcome.	Baseline and 12 weeks
Chang in weight of muscle and fat from baseline to 12 weeks	muscle mass(kg/%), fat mass (kg/%)	Baseline and 12 weeks
Chang in Activities of Daily Living from baseline to 12 weeks	This is a scale of physical function. The range for total score is 0-100. A Higher score means a worse outcome.	Baseline and 12 weeks
Chang in Instrumental activities of daily living from baseline to 12 weeks	This is a scale of physical function. The range for total score is 0-24. A Higher score means a better outcome.	Baseline and 12 weeks
Chang in short form Berg balance scale from baseline to 12 weeks	Balance Assessment. The range is 0-4. A Higher score means a better outcome.	Baseline and 12 weeks
Chang in Gait analyses from wearable sensors from baseline to 12 weeks	MTC mean magnitude and variability, as well as the stride-to-stride variability, stride time and length, lower limb peak angular velocity, and foot forward linear speed	Baseline and 12 weeks
Chang in EQ5D from baseline to 12 weeks	This is a scale of quality of life. The range for total is 0-20. A higher score means a worse outcome.	Baseline and 12 weeks
Chang in WHOBREF from baseline to 12 weeks	This is a scale of quality of life. A higher score means a better outcome.	Baseline and 12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
age, gender, married, religion, sleep, fall, disease status, education	Demographic basic data	Baseline
height, weight	height(cm), weight(kg)	Baseline
Clinical Dementia Rating	Mental Function Assessment. The range is 0-3. A Higher score means a worse outcome.	Baseline
Chang in Cumulative Illness Rating Scale	A Higher score means a worse outcome. Range Min and Max to 0-56.	Baseline

Collaborators and Investigators

• Sponsor: Central Taiwan University of Science and Technology
• Investigators: Principal Investigator: Chiu, Central Taiwan University of Science and Technology

Study record dates

Study Major Dates

• Study Start (Actual): May 3, 2024
• Primary Completion (Actual): September 12, 2024
• Study Completion (Actual): April 30, 2025

Study Registration Dates

• First Submitted: August 6, 2024
• First Submitted That Met QC Criteria: August 8, 2024
• First Posted (Actual): August 13, 2024

Study Record Updates

• Last Update Posted (Actual): August 6, 2025
• Last Update Submitted That Met QC Criteria: August 3, 2025
• Last Verified: August 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: CTU112-SHOW-002

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No